Form 4: AbbVie Director Waddell Reports Stock Unit Acquisition
Insider Transaction Report
AbbVie Inc. director Frederick H. Waddell acquired restricted stock units under the company's incentive program.
Summary
- Frederick H. Waddell, a Director at AbbVie Inc., acquired 1,118 restricted stock units (RSUs) on May 8, 2026.
- These RSUs were awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program.
- The RSUs will be settled on a one-to-one basis in shares of AbbVie common stock.
- Settlement will occur upon the director's separation from service, death, or a change in control.
- Following this transaction, Waddell beneficially owns 30,076 shares of common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine award of stock units to a director under an existing incentive plan, rather than a significant new strategic development or financial performance indicator.
Positives
- Director acquisition of stock units indicates continued alignment with shareholder interests.
- The award is part of a long-standing incentive program designed to retain key personnel.
Risks
- The value of the RSUs is subject to fluctuations in AbbVie's stock price.
- Vesting and settlement are contingent upon specific events such as separation, death, or change in control.
Future Outlook
The restricted stock units will be paid out in shares of AbbVie common stock upon the occurrence of specific events, including separation from service, death, or a change in control.
Industry Context
StockSavvy.ai notes that insider awards of restricted stock units are a common practice in the pharmaceutical and biotechnology sectors, serving as a tool for executive retention and aligning management's interests with long-term shareholder value.
Stakeholder Impact
- Shareholders: The acquisition of stock units by a director reinforces alignment of management interests with shareholder value.
- Employees: The incentive program highlights the company's commitment to retaining key talent through equity-based compensation.
Next Steps
- Settlement of restricted stock units upon director's separation from service, death, or change in control.
Key Dates
| Date | Description |
|---|---|
| 05/08/2026 | Transaction Date for acquisition of restricted stock units. |
| 05/12/2026 | Date of signature for the filing. |
Keywords
AbbVie Inc., ABBV, Form 4, Insider Trading, Restricted Stock Units, Incentive Stock Program, Director Compensation, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.